Literature DB >> 12537762

Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findings.

Sarah Kohn1, Milo Fradis, Jacob Ben-David, Jamal Zidan, Eliezer Robinson.   

Abstract

The drugs cisplatin and gentamicin are given consecutively to various cancer patients suffering from infections. Little information exists about the ultrastructural alterations of kidney glomeruli caused by treatment with these drugs. Renal glomeruli of guinea pigs treated with cisplatin alone and in combination with gentamicin were studied by transmission electron microscopy. The findings revealed foci of damage induced by cisplatin and especially by cisplatin/gentamicin in all glomerular components: glomerular capillaries, including their endothelial cells; basement membrane, epithelial podocytes, mesangial cells, and parietal cells of Bowman's capsule. The damage was expressed by endothelial cytoplasmic extrusions into the vascular lumen, thickening and lamination of capillary basement membrane, focal foot process fusion of podocytes, vacuolization in cytoplasm of endothelial cells of epithelial podocytes and of parietal cells, and the presence of lipid bodies and myeloid bodies in all glomerular cell types. Additionally, injurious effects to cytoplasmic organelles such as mitochondria, nuclei, and endoplasmic reticulum were observed. The results indicate that cisplatin alone and in combination with gentamicin is toxic to renal glomerular tissue. Since these drugs were previously found toxic for strial capillaries in the inner ear and since the main glomerular component is the glomerular capillaries, potential vascular damage and vascular complications in different body systems have to be taken into consideration when these drugs are needed in clinical use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537762     DOI: 10.1080/01913120290104683

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  8 in total

1.  Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.

Authors:  A Muscella; C Vetrugno; F Biagioni; N Calabriso; M T Calierno; F Fornai; S A De Pascali; S Marsigliante; F P Fanizzi
Journal:  Br J Pharmacol       Date:  2016-07-22       Impact factor: 8.739

2.  Effects of cisplatin on the contractile function of thoracic aorta of Sprague-Dawley rats.

Authors:  Ying Jiang; Shigang Shan; Tieer Gan; Xiaoyun Zhang; Xianghong Lu; Hu Hu; Yihua Wu; Jianzhong Sheng; Jun Yang
Journal:  Biomed Rep       Date:  2014-08-19

3.  Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.

Authors:  Ayako Watanabe; Akiko Tanabe; Risa Maruoka; Kiyoko Nakamura; Koji Hatta; Yoshihiro J Ono; Yoshito Terai; Masahide Ohmichi
Journal:  Int J Clin Oncol       Date:  2014-12-26       Impact factor: 3.402

Review 4.  An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

Authors:  George J Dugbartey; Luke J Peppone; Inge A M de Graaf
Journal:  Toxicology       Date:  2016-10-04       Impact factor: 4.221

5.  Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.

Authors:  P Giordano; G Lorito; A Ciorba; A Martini; S Hatzopoulos
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-08       Impact factor: 2.124

6.  Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.

Authors:  Anna Menshikh; Lauren Scarfe; Rachel Delgado; Charlene Finney; Yuantee Zhu; Haichun Yang; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-11

7.  Cisplatin-induced haemolytic uraemic syndrome associated with a novel intronic mutation of CD46 treated with eculizumab.

Authors:  Rodney D Gilbert; Louise K Stanley; Darren J Fowler; Elizabeth M Angus; Steven A Hardy; Timothy H Goodship
Journal:  Clin Kidney J       Date:  2013-08

Review 8.  Cisplatin-induced renal toxicity in elderly people.

Authors:  ZhiYu Duan; GuangYan Cai; JiJun Li; XiangMei Chen
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.